Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.66 uM | Inhibition of human DMT1 expressed in CHO cells assessed as blockage of ferrous influx after 20 mins by calcein fluorescence quenching method | ChEMBL. | 22154351 |
Inhibition (ADMET) | = 14 % | Inhibition of human recombinant CYP3A4 at 10 uM | ChEMBL. | 22154351 |
permeability (ADMET) | = 9 10'-6 cm/s | Permeability from apical to basolateral side in human Caco2 cells | ChEMBL. | 22154351 |
permeability (ADMET) | = 15.4 10'-6 cm/s | Permeability from basolateral to apical side in human Caco2 cells | ChEMBL. | 22154351 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.